Moreover, aberrant expression of EMX2 has been reported to be correlated with the development of cancer originated from melanocytes (a derivative of the neural crest), including melanoma (Bordogna et al., 2005) and GBM (Monnier et al., 2018). This evidence concerns the gene EMX2 and glioblastoma.